Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Health Canada Approves Biocon and Mylan's Ogivri™, the First Trastuzumab Biosimilar

Posted On: 2019-05-24 10:40:10

Biocon Ltd. and Mylan N.V. has announced that Health Canada has approved Mylan's Ogivri™ (trastuzumab), a biosimilar to Herceptin®1 (trastuzumab) co-developed with Biocon, for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).

Ogivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the market. Mylan plans to launch the product this quarter and anticipates potentially being the first company to offer a trastuzumab biosimilar in Canada.

Dr Christiane Hamacher, CEO, Biocon Biologics said, "We are pleased to enable access to Ogivri, a high quality biosimilar trastuzumab co-developed and manufactured by Biocon as an affordable treatment option for HER2- positive breast and gastric cancer patients in Canada. The Health Canada approval granted to Ogivri, will pave the way for its commercialization by our partner Mylan. Thousands of patients in Europe, India and key emerging markets are benefitting from our biosimilar trastuzumab. Biocon Biologics is committed to address unmet patient needs through its high quality, affordable biologics, globally."

Mylan's Chief Commercial Officer Tony Mauro commented, "As a global leader in the development of complex products, including biosimilar medicines, we're pleased to reach this approval milestone for Ogivri and the opportunity to bring this important treatment option to market for Canadian patients with HER2-positive breast and gastric cancers. We look forward to continuing our reimbursement discussions with the Canadian Agency for Drugs and Technologies in Health (CADTH) and the Pan-Canadian Pharmaceutical Alliance (pCPA} to ensure that patients have access to Ogivri."

Approval by Health Canada was based on robust data from structural and functional characterization using multiple orthogonal techniques, nonclinical studies and pharmacokinetic evaluation in healthy subjects and patients and a safety, efficacy and immunogenicity study in relevant patient populations, which compared Ogivri to Herceptin. The data demonstrated that Ogivri is highly similar to Herceptin with no clinically meaningful differences in terms of efficacy, safety, purity and potency.

Biocon and Mylan's trastuzumab biosimilar is currently approved in more than 65 countries around the world, including the U.S.

Shares of BIOCON LTD. was last trading in BSE at Rs.510.7 as compared to the previous close of Rs. 519.6. The total number of shares traded during the day was 144554 in over 3535 trades.

The stock hit an intraday high of Rs. 526.95 and intraday low of 509.05. The net turnover during the day was Rs. 74890459.

1 Herceptin® is a product of Hoffmann-La Roche Ltd.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Spirit of Wipro Run Brings Together Participants from 110 Cities Across 34 Nations

Cigniti Technologies Ltd bags 'Corporate Leader of the Year' award at I-ACE awards

Thyrocare Technologies Ltd updates on stake sale in Nueclear Healthcare Ltd

Thomas Cook India, a separate entity and Thomas Cook UK has no stake in India Company

Shri P Jayarama Bhat elected as the Chairman of the governing board of SIBSTC, Bengaluru

Bricwork revises credit rating of Edelweiss Financial Services' NCDs

Capital India Finance Ltd acquires stae in Rapipay Fintech Holding Pvt Ltd

Ravindra Energy Ltd bags contract

Bank of Maharashtra and Paisalo Digital Limited sign Co-Origination of Loan Agreement

Shilpa Medicare Ltd gets shareholders nod for final dividend

Fredun Pharmaceuticals Ltd receives award from Saraswat Co-Operative Bank Ltd

Jump Networks Ltd inks agreement to become the principal sponsor of The Forca Goa Foundation

Sundaram-Clayton Ltd board to approve quarterly results on Oct 18, 2019

Filatex India Ltd updates on expansion project

Karnataka Bank wins ET BUSINESS EXCELLENCE AWARD 2019

Biocon Ltd updates on pre-approval inspection by US FDA

Dhunseri Ventures Limited updates on ratings

Wanbury Ltd approves debt settlement and fund raising through brand sale

ICRA updates on Canara Bank's Basel III compliant Tier II bonds

Commercial Engineers & Body Builders Co Ltd to form JV

GOCL Corporation Ltd board to consider special interim dividend on Sep 27, 2019

Adani Group recognised as the best coal service provider at Mjunction awards

W S Industries India Ltd board approves roll over of preference shares

TVS Motor Company Ltd board to announce Q2, H1 results on Oct 17, 2019

Asian Granito in Fortune India's List as one of The Next Fortune 500 companies

Pantaloons Celebrates the Pujo Rockstars this Pujo with its new campaign

Indian Overseas Bank celebrates Hindi Month - 2019

Alkem Laboratories Ltd acquires undertaking from subsidiary

Sakthi Sugars Ltd agrees for OTS with Bank of India

Pidilite Industries Ltd forms subsidiary

Corporate Tax reduction - Mr. Kamlesh Patel, Chairman and Managing Director - Asian Granito India Ltd

Seamec Ltd announces extension of long term charter for SEAMEC II with HAL Offshore Ltd

Nippon Express to Acquire 22% Stake in Future Supply Chain Solutions Ltd

Hexaware's Salesforce practice has been awarded Gold Consulting Partner status

Lupin receives sANDA approval from U.S. FDA for Levothyroxine Sodium Tablets USP to be considered AB rated to Reference Listed Drug, UNITHROID®

USFDA approval for Unichem Laboratories Ltd's plant at Kolhapur

Zensar Recognized in the 2019 Gartner Magic Quadrant for Data Center Outsourcing and Hybrid Infrastructure Managed Services, North America

Asian Paints launches 'AP Homes' in Bengaluru, its state-of-the-art multi-category décor showroom

Allahabad Bank Introduces External Benchmark Linked Loans under Retail and Micro & Small Enterprises

IndiGo inaugurates flights between India and Myanmar

Strides Board approves incremental investments in Stelis

Himatsingka Seide Ltd board approves investment of Rs. 17.34 crore in wind power SPVs

AXIS Bank Ltd board to consider Q2 results on Oct 21, 2019

Bingo! Pujo Tadka enlivens the festive spirit of Durga Pujo

Just Launched: Official App for TCS Lidingöloppet 2019 Packed with Exciting New Features

Raksha Mantri inaugurates Engineers Conclave (2019), Product Development & Innovation Centre of BEL

Redington offering the latest products from Apple, including iPhone 11 Pro and iPhone 11 Pro Max

Dilip Buildcon Ltd completes road project in Punjab

Anuh Pharma Ltd successfully completes USFDA inspection

Bajaj Electricals Limited receives 2019 ASCM Corporate Award of Excellence for Advance Supply Chain Industry







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019